Abstract:Purpose/background: Visual acuity (VA) screening in children primarily detects low VA and amblyopia between 3 and 6 years of age. Photoscreening is a low-cost, lower-expertise alternative which can be carried out on younger children and looks instead for refractive amblyopia risk factors so that early glasses may prevent or mitigate the conditions. The long-term benefits and costs of providing many children with glasses in an attempt to avoid development of amblyopia for some of them needs clarification. This paper presents a framework for modeling potential post-referral costs of different screening models once referred children reach specialist services. Methods: The EUSCREEN Screening Cost-Effectiveness Model was used together with published literature to estimate referral rates and case mix of referrals from different screening modalities (photoscreening and VA screening at 2, 3-4 years and 4-5 years). UK 2019-20 published National Health Service (NHS) costings were used across all scenarios to model the comparative post-referral costs to the point of discharge from specialist services. Potential costs were compared between a) orthoptist, b) state funded ophthalmologist and c) private ophthalmologist care. Results: Earlier VA screening and photoscreening yield higher numbers of referrals because of lower sensitivity and specificity for disease, and a different case mix, compared to later VA screening. Photoscreening referrals are a mixture of reduced VA caused by amblyopia and refractive error, and children with amblyopia risk factors, most of which are treated with glasses. Costs relate mainly to the secondary care providers and the number of visits per child. Treatment by an ophthalmologist of a referral at 2 years of age can be more than x10 more expensive than an orthoptist service receiving referrals at 5 years, but outcomes can still be good from referrals aged 5. Conclusions: All children should be screened for amblyopia and low vision before the age of 6. Very early detection of amblyopia refractive risk factors may prevent or mitigate amblyopia for some affected children, but population-level outcomes from a single high-quality VA screening at 4-5 years can also be very good. Total patient-journey costs incurred by earlier detection and treatment are much higher than if screening is carried out later because younger children need more professional input before discharge, so early screening is less cost-effective in the long term. Population coverage, local healthcare models, local case-mix, public health awareness, training, data monitoring and audit are critical factors to consider when planning, evaluating, or changing any screening programme.

Evaluation of the iScreen digital screening system for amblyogenic factors

Photoscreening for refractive errors in children and young adults with severe learning disabilities using the MTI photoscreener

Comparison Between the plusoptiX and MTI Photoscreeners

Refinement strategies in photoscreening for the detection of amblyopia risk factors in 12-to-24-month-old children

Artificial intelligence-based screening for amblyopia and its risk factors: comparison with four classic stereovision tests

Technical Report: A New Device Attached to a Smartphone for Objective Vision Screening

Reliability of a computerized system for strabismus screening

Validation of the eye screening tool GoCheck Kids for the detection of amblyopia risk factors in toddlers in Flanders

Amblyopia Care Trends Following Widespread Photoscreener Adoption

[Possibilities and limitations of amblyopia screening with auto-refractometers]

AAPOS uniform guidelines for instrument-based pediatric vision screen validation 2021

A population-level post-screening treatment cost framework to help inform vision screening choices for children under the age of seven

Economic evaluations of vision screening to detect amblyopia and refractive errors in children: a systematic review

Refractive errors, amblyopia risk factors and vision screening in children aged 7-10 years in Aotearoa New Zealand

Amblyopia, Strabismus and Refractive Errors in Congenital Ptosis: a Systematic Review and Meta-Analysis

Prediction and cost-effectiveness comparison of amblyopia screening methods at ages 3-4 years

Instrument referral criteria for PlusoptiX and SureSight based on 2021 AAPOS guidelines: A population-based study

Telemedicine Screening of Retinal Diseases with a Handheld Portable Non-Mydriatic Fundus Camera

Early Detection of Refractive Errors by Photorefraction at School Age

PHOTOREFRACTION: A USEFUL TOOL TO DETECT REFRACTION ERRORS